JPH0430278B2 - - Google Patents

Info

Publication number
JPH0430278B2
JPH0430278B2 JP60201445A JP20144585A JPH0430278B2 JP H0430278 B2 JPH0430278 B2 JP H0430278B2 JP 60201445 A JP60201445 A JP 60201445A JP 20144585 A JP20144585 A JP 20144585A JP H0430278 B2 JPH0430278 B2 JP H0430278B2
Authority
JP
Japan
Prior art keywords
hybridoma
cells
adriamycin
resistant
mouse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60201445A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6261596A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP60201445A priority Critical patent/JPS6261596A/ja
Priority to DE8686112391T priority patent/DE3685533T2/de
Priority to EP86112391A priority patent/EP0214640B1/en
Priority to AT86112391T priority patent/ATE76904T1/de
Publication of JPS6261596A publication Critical patent/JPS6261596A/ja
Priority to US07/593,276 priority patent/US5087560A/en
Publication of JPH0430278B2 publication Critical patent/JPH0430278B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/861—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP60201445A 1985-09-11 1985-09-11 薬剤耐性癌に関するモノクロ−ナル抗体およびその製造 Granted JPS6261596A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP60201445A JPS6261596A (ja) 1985-09-11 1985-09-11 薬剤耐性癌に関するモノクロ−ナル抗体およびその製造
DE8686112391T DE3685533T2 (de) 1985-09-11 1986-09-08 Monoklonaler antikoerper in bezug auf heilmittelresistente krebse und dessen herstellung.
EP86112391A EP0214640B1 (en) 1985-09-11 1986-09-08 Monoclonal antibody in relation to drug-resistant cancers and production thereof
AT86112391T ATE76904T1 (de) 1985-09-11 1986-09-08 Monoklonaler antikoerper in bezug auf heilmittelresistente krebse und dessen herstellung.
US07/593,276 US5087560A (en) 1985-09-11 1990-10-01 Monoclonal antibody for use in drug resistant cancers and production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60201445A JPS6261596A (ja) 1985-09-11 1985-09-11 薬剤耐性癌に関するモノクロ−ナル抗体およびその製造

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP3309471A Division JPH0661264B2 (ja) 1991-11-25 1991-11-25 薬剤耐性癌に関するモノクローナル抗体生産性ハイブリドーマ

Publications (2)

Publication Number Publication Date
JPS6261596A JPS6261596A (ja) 1987-03-18
JPH0430278B2 true JPH0430278B2 (https=) 1992-05-21

Family

ID=16441205

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60201445A Granted JPS6261596A (ja) 1985-09-11 1985-09-11 薬剤耐性癌に関するモノクロ−ナル抗体およびその製造

Country Status (5)

Country Link
US (1) US5087560A (https=)
EP (1) EP0214640B1 (https=)
JP (1) JPS6261596A (https=)
AT (1) ATE76904T1 (https=)
DE (1) DE3685533T2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2564412B2 (ja) * 1990-03-02 1996-12-18 財団法人癌研究会 薬剤耐性癌に対するキメラ抗体およびその製造
WO1992008802A1 (en) * 1990-10-29 1992-05-29 Cetus Oncology Corporation Bispecific antibodies, method of production, and uses thereof
US20080124329A1 (en) * 2006-07-05 2008-05-29 Schreiner George F Conditioned Cell Immunization
FR2906533B1 (fr) * 2006-09-28 2013-02-22 Pf Medicament Procede de generation d'anticorps actifs contre un antigene de resistance,anticorps obtenus par ledit procede et leurs utilisations

Also Published As

Publication number Publication date
US5087560A (en) 1992-02-11
DE3685533D1 (de) 1992-07-09
DE3685533T2 (de) 1993-02-18
JPS6261596A (ja) 1987-03-18
EP0214640A2 (en) 1987-03-18
ATE76904T1 (de) 1992-06-15
EP0214640B1 (en) 1992-06-03
EP0214640A3 (en) 1988-11-30

Similar Documents

Publication Publication Date Title
JP2837160B2 (ja) ヒト腫瘍壊死因子に対するモノクローナル抗体を含有する敗血症治療薬及びリューマチ性疾患治療薬
US4661586A (en) Monoclonal anti-idiotype antibodies
JPS5845407B2 (ja) 悪性腫瘍抗体の製造方法
US4816249A (en) Monoclonal anti-idiotype antibodies
US5766946A (en) Monoclonal antibodies to glycoprotein P
US5084380A (en) Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
US4898932A (en) Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
JPH0430278B2 (https=)
FI90988B (fi) Monoklonaaliset vasta-aineet natriumdiureesia lisääviä nisäkkäiden sydäneteisen peptidejä kohtaan
JPH09176199A (ja) 抗ファクターＸａ・ティシュファクターパスウェイインヒビター複合体モノクローナル抗体及びその使用
JPH02497A (ja) ヒト前立腺特異性抗原に対する抗体組成物
US4820641A (en) Monoclonal antibody capable of specifically distinguishing human hepato-carcinoma cells
US5798213A (en) Monoclonal antibodies
JP4493882B2 (ja) 抗原およびこの抗原を識別するモノクローナル抗体
JPH0421479B2 (https=)
JPS63222699A (ja) 単クローン性抗体及びこれを用いるシユードウリジンψの測定法
JPH05219946A (ja) 薬剤耐性癌に関するモノクローナル抗体生産性ハイブリドーマ
JPH04304897A (ja) 抗イディオタイプモノクローナル抗体
JP2845568B2 (ja) モノクローナル抗体
JPS61249999A (ja) モノクロ−ナル抗体
JP2004091453A (ja) モノクローナル抗体及びその製造方法並びにモノクローナル抗体を用いた抗原の定量方法
JPH0379994B2 (https=)
JP2004091454A (ja) 抗体及びその製造方法並びに抗体を用いた抗原の定量方法
JP3461365B2 (ja) モノクローナル抗体
JPS6233199A (ja) モノクロ−ナル抗体

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees